Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Concord Healthcare Group Co., Ltd. Class H ( (HK:2453) ).
Concord Healthcare Group has completed the placement of HK$68 million in convertible bonds under its general mandate, with all conditions under the placing and subscription agreement satisfied as of 13 May 2026. The bonds are convertible into H shares at an initial conversion price of HK$1.70 per share, providing the company with additional capital while using its existing shareholder authorization.
The company stated that all potential adjustments to the conversion price are within its control and it does not expect actions that would cause conversion shares to exceed the current mandate limit. If future adjustments did create an excess, the company intends to rely on a fresh general mandate granted on 11 May 2026, and a full bond conversion would increase total share capital to 823,662,016 shares, introducing a new H-share subscriber with about 4.86% of the enlarged share base and modestly diluting existing shareholders.
More about Concord Healthcare Group Co., Ltd. Class H
Concord Healthcare Group Co., Ltd. is a healthcare company incorporated in the People’s Republic of China and listed in Hong Kong, with both H shares and domestic shares in issue. The group operates within the medical and healthcare services sector, serving domestic and international investors through its dual-share structure in the Hong Kong market.
Average Trading Volume: 488,614
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.17B
Learn more about 2453 stock on TipRanks’ Stock Analysis page.